Fairfield, Bush & Co’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Buy |
14,549
+1,387
| +11% | +$98.9K | 0.61% | 41 |
|
|
2025
Q4 | $812K | Sell |
13,162
-297
| -2% | -$17.5K | 0.43% | 58 |
|
|
2025
Q3 | $790K | Sell |
13,459
-447
| -3% | -$26.1K | 0.41% | 58 |
|
|
2025
Q2 | $810K | Sell |
13,906
-1,347
| -9% | -$76.1K | 0.46% | 57 |
|
|
2025
Q1 | $758K | Sell |
15,253
-1,897
| -11% | -$97.1K | 0.48% | 57 |
|
|
2024
Q4 | $767K | Sell |
17,150
-197
| -1% | -$9.35K | 0.45% | 60 |
|
|
2024
Q3 | $834K | Sell |
17,347
-1,197
| -6% | -$57.7K | 0.5% | 54 |
|
|
2024
Q2 | $944K | Sell |
18,544
-209
| -1% | -$11.4K | 0.57% | 48 |
|
|
2024
Q1 | $1.02M | Sell |
18,753
-497
| -3% | -$25.9K | 0.6% | 47 |
|
|
2023
Q4 | $1.08M | Sell |
19,250
-1,563
| -8% | -$88.3K | 0.64% | 42 |
|
|
2023
Q3 | $1.29M | Sell |
20,813
-1,118
| -5% | -$70.7K | 0.84% | 35 |
|
|
2023
Q2 | $1.3M | Buy |
21,931
+1,916
| +10% | +$122K | 0.36% | 61 |
|
|
2023
Q1 | $1.48M | Sell |
20,015
-148
| -0.7% | -$11.4K | 0.52% | 47 |
|
|
2022
Q4 | $1.47M | Buy |
20,163
+1
| +0% | +$79 | 0.97% | 26 |
|
|
2022
Q3 | $1.68M | Sell |
20,162
-2,268
| -10% | -$195K | 1.19% | 23 |
|
|
2022
Q2 | $1.79M | Sell |
22,430
-485
| -2% | -$47.1K | 1.05% | 23 |
|
|
2022
Q1 | $2.38M | Sell |
22,915
-3,780
| -14% | -$313K | 1.2% | 23 |
|
|
2021
Q4 | $2.01M | Sell |
26,695
-1,526
| -5% | -$107K | 0.96% | 26 |
|
|
2021
Q3 | $1.83M | Buy |
28,221
+263
| +0.9% | +$16.1K | 0.59% | 46 |
|
|
2021
Q2 | $1.7M | Buy |
27,958
+2,636
| +10% | +$156K | 0.46% | 47 |
|
|
2021
Q1 | $1.36M | Buy |
25,322
+2,110
| +9% | +$115K | 0.39% | 57 |
|
|
2020
Q4 | $1.12M | Buy |
23,212
+850
| +4% | +$37.6K | 0.33% | 68 |
|
|
2020
Q3 | $877K | Buy |
+22,362
| New | +$814K | 0.28% | 72 |
|
|
2020
Q2 | – | Sell |
-6,882
| Closed | -$234K | – | 148 |
|
|
2020
Q1 | $234K | Sell |
6,882
-1,500
| -18% | -$60K | 0.1% | 110 |
|
|
2019
Q4 | $402K | Hold |
8,382
| – | – | 0.15% | 103 |
|
|
2019
Q3 | $418K | Sell |
8,382
-1,500
| -15% | -$76.5K | 0.14% | 101 |
|
|
2019
Q2 | $528K | Hold |
9,882
| – | – | 0.18% | 92 |
|
|
2019
Q1 | $521K | Sell |
9,882
-2,200
| -18% | -$115K | 0.17% | 93 |
|
|
2018
Q4 | $568K | Sell |
12,082
-1,100
| -8% | -$57.4K | 0.2% | 92 |
|
|
2018
Q3 | $761K | Hold |
13,182
| – | – | 0.21% | 88 |
|
|
2018
Q2 | $717K | Buy |
13,182
+1,000
| +8% | +$49.6K | 0.21% | 87 |
|
|
2018
Q1 | $576K | Buy |
+12,182
| New | +$610K | 0.17% | 99 |
|
Other funds holding NTR
VCM
Fairfield, Bush & Co's NTR Position: Q1 2026 in Review
Fairfield, Bush & Co increased its Nutrien (NTR) stake by 11% in Q1 2026, buying an estimated $98.9K and bringing the position to 14,549 shares worth $1.1M. The position accounts for 0.61% of the portfolio, ranked #41.
Fairfield, Bush & Co first reported a position in NTR in Q1 2018 and has held it in 32 quarters since. The position peaked at $2.38M in Q1 2022. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Fairfield, Bush & Co held 14,549 shares of Nutrien worth $1.1M as of Q1 2026.
- Fairfield, Bush & Co bought 1,387 Nutrien shares in Q1 2026, an estimated $98.9K.
- Nutrien made up 0.61% of Fairfield, Bush & Co's portfolio in Q1 2026, its #41 holding.
- Fairfield, Bush & Co first reported a position in Nutrien in Q1 2018 and has held it in 32 quarters since.
- Fairfield, Bush & Co's Nutrien position peaked at $2.38M in Q1 2022.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.